Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
APMC-Annals of Punjab Medical College. 2011; 5 (1): 19-22
Dans Anglais | IMEMR | ID: emr-175239

Résumé

Objectives: To compare the efficacy and safety of Misoprostol for termination of pregnancy in second trimester in scarred versus unscarred uterus


Study Design: Quasi-experimental study


Setting: Obstetrics and Gynaecology unit of Allied / DHQ Hospitals affiliated with Punjab Medical College, Faisalabad


Subjects and Method: During 6 months period from 22nd March, 2007 to 22nd September, 2007. 60 patients [30 with scarred and 30 with unscarred uterus] were admitted for second trimester termination of pregnancy for maternal reason, fetal congenital anomalies and intrauterine fetal demise and induced with vaginal misoprostol. Loading dose of 400 mcg followed by maintenance dose of 200 mcg at 4 hourly interval to a maximum of 4 doses


Main Outcome Measures: Efficacy included induction to delivery interval and safety included maternal complications and side effects like uterine rupture, hysterectomy, severe haemorrhage, pyrexia, nausea and vomiting


Results: Success rate of T.O.P. was 96.7% in group A [scarred uterus] VS 93.3% in group B [unscarred uterus] Maternal complications were nausea and vomiting 3.3% in group A VS 0% in group B, Pyrexia 3.3% in each group, no case of uterine rupture was recorded


Conclusion: Misoprostol is safe and effective drug for Midtrimester T.O.P. in scarred as well as unscarred uterus

SÉLECTION CITATIONS
Détails de la recherche